A carregar...
Immunomodulation of T(H)2 biased immunity with mucosal administration of nanoemulsion adjuvant
T(H)2-biased immune responses are associated with inadequate protection against some pathogens and with cancer, colitis, asthma and allergy. Since most currently used vaccine adjuvants induce a T(H)2-biased response, this has led to interest in developing adjuvants capable of activating T(H)1 immuni...
Na minha lista:
| Publicado no: | Vaccine |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Science
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4962973/ https://ncbi.nlm.nih.gov/pubmed/27317451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.06.043 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|